SBFM
Price
$1.07
Change
+$0.01 (+0.94%)
Updated
Sep 14 closing price
Capitalization
4.11M
56 days until earnings call
Intraday BUY SELL Signals
SIGA
Price
$3.15
Change
+$0.12 (+3.96%)
Updated
Sep 14 closing price
Capitalization
225.97M
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SBFM vs SIGA

SBFM vs SIGA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
SBFM vs. SIGA commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBFM is a Hold and SIGA is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SIGA($226M) has a higher market cap than SBFM($4.11M). SIGA has higher P/E ratio than SBFM: SIGA (11.14) vs SBFM (0.20). SIGA YTD gains are higher at: -41.721 vs. SBFM (-91.301). SBFM has higher annual earnings (EBITDA): -6.32M vs. SIGA (-10.55M). SIGA has more cash in the bank: 118M vs. SBFM (13.7M). SIGA has less debt than SBFM: SIGA (439K) vs SBFM (678K). SIGA has higher revenues than SBFM: SIGA (53.7M) vs SBFM (35.3M).
SBFMSIGASBFM / SIGA
Capitalization4.11M226M2%
EBITDA-6.32M-10.55M60%
Gain YTD-91.301-41.721219%
P/E Ratio0.2011.142%
Revenue35.3M53.7M66%
Total Cash13.7M118M12%
Total Debt678K439K154%
FUNDAMENTALS RATINGS
SBFM vs SIGA: Fundamental Ratings
SBFM
SIGA
OUTLOOK RATING
1..100
4433
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
1
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9691
PRICE GROWTH RATING
1..100
9265
P/E GROWTH RATING
1..100
809
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIGA's Valuation (1) in the Pharmaceuticals Other industry is in the same range as SBFM (21) in the null industry. This means that SIGA’s stock grew similarly to SBFM’s over the last 12 months.

SIGA's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as SBFM (100) in the null industry. This means that SIGA’s stock grew similarly to SBFM’s over the last 12 months.

SIGA's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as SBFM (96) in the null industry. This means that SIGA’s stock grew similarly to SBFM’s over the last 12 months.

SIGA's Price Growth Rating (65) in the Pharmaceuticals Other industry is in the same range as SBFM (92) in the null industry. This means that SIGA’s stock grew similarly to SBFM’s over the last 12 months.

SIGA's P/E Growth Rating (9) in the Pharmaceuticals Other industry is significantly better than the same rating for SBFM (80) in the null industry. This means that SIGA’s stock grew significantly faster than SBFM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SBFMSIGA
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
70%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
75%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
COMPARISON
Comparison
Sep 15, 2026
Stock price -- (SBFM: $1.07 vs. SIGA: $3.15)
Brand notoriety: SBFM and SIGA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: SBFM: 17% vs. SIGA: 72%
Market capitalization -- SBFM: $4.11M vs. SIGA: $225.97M
SBFM [@Pharmaceuticals: Generic] is valued at $4.11M. SIGA’s [@Pharmaceuticals: Generic] market capitalization is $225.97M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $63.66B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SBFM’s FA Score shows that 1 FA rating(s) are green while SIGA’s FA Score has 2 green FA rating(s).

  • SBFM’s FA Score: 1 green, 4 red.
  • SIGA’s FA Score: 2 green, 3 red.
According to our system of comparison, SIGA is a better buy in the long-term than SBFM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SBFM’s TA Score shows that 3 TA indicator(s) are bullish while SIGA’s TA Score has 6 bullish TA indicator(s).

  • SBFM’s TA Score: 3 bullish, 3 bearish.
  • SIGA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SIGA is a better buy in the short-term than SBFM.

Price Growth

SBFM (@Pharmaceuticals: Generic) experienced а -6.14% price change this week, while SIGA (@Pharmaceuticals: Generic) price change was -4.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.68%. For the same industry, the average monthly price growth was -3.54%, and the average quarterly price growth was +33.30%.

Reported Earning Dates

SBFM is expected to report earnings on Nov 10, 2026.

SIGA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.68% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
SBFM
Daily Signal:
Gain/Loss:
SIGA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YETI40.830.57
+1.42%
YETI Holdings
CRMD7.890.07
+0.83%
CorMedix
DINO106.91-0.93
-0.86%
HF Sinclair Corp
CETX2.39-0.03
-1.24%
Cemtrex Inc
GUTS0.61-0.03
-4.44%
Fractyl Health

SBFM and

Correlation & Price change

A.I.dvisor tells us that SBFM and OGI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
+0.94%
OGI - SBFM
28%
Poorly correlated
+2.38%
CGC - SBFM
24%
Poorly correlated
+1.15%
TLRY - SBFM
24%
Poorly correlated
+2.99%
ELAN - SBFM
23%
Poorly correlated
-0.09%
AMRX - SBFM
23%
Poorly correlated
+1.23%
More

SIGA and

Correlation & Price change

A.I.dvisor tells us that SIGA and EBS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGA and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGA
1D Price
Change %
SIGA100%
+3.96%
EBS - SIGA
31%
Poorly correlated
+2.41%
ETON - SIGA
27%
Poorly correlated
+0.95%
HROW - SIGA
27%
Poorly correlated
-1.19%
AMRX - SIGA
26%
Poorly correlated
+1.23%
SBFM - SIGA
25%
Poorly correlated
+0.94%
More